Latest US Food and Drug Administration Stories
RESEARCH TRIANGLE PARK, N.C., Feb.
CARLSBAD, Calif., Jan. 28 /PRNewswire/ -- Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.
SAN DIEGO, Dec. 22, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
MOUNTAIN VIEW, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that it has submitted its New Drug Application (NDA) for StaccatoÂ® loxapine (AZ-004) to the US Food and Drug Administration (FDA).
WILMINGTON, Del., Dec.
ROCKLAND, Mass., Nov.
SAN DIEGO, Nov.
SAN DIEGO, Oct.
PRINCETON, N.J., Oct.
IRVINE, Calif., Oct.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.